Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,capitalSurplus,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,retainedEarnings,otherLiab,otherAssets,cash,totalCurrentLiabilities,propertyPlantEquipment,totalCurrentAssets,shortTermInvestments,netReceivables,accountsPayable,otherCurrentAssets,investments,changeToLiabilities,totalCashflowsFromInvestingActivities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,issuanceOfStock,changeInCash,effectOfExchangeRate,totalCashFromOperatingActivities,depreciation,changeToAccountReceivables,otherCashflowsFromFinancingActivities,changeToNetincome,capitalExpenditures,WC,language,region,quoteType,triggerable,quoteSourceName,currency,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,epsTrailingTwelveMonths,epsForward,epsCurrentYear,priceEpsCurrentYear,gmtOffSetMilliseconds,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,priceHint,shortName,longName,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,marketState,exchange,market,twoHundredDayAverageChangePercent,marketCap,forwardPE,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,esgPopulated,tradeable,exchangeDataDelayedBy,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,"Shares Short (Jul 29, 2021) 4","Short Ratio (Jul 29, 2021) 4","Short % of Float (Jul 29, 2021) 4","Short % of Shares Outstanding (Jul 29, 2021) 4","Shares Short (prior month Jun 29, 2021) 4",Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,longBusinessSummary,city,phone,compensationAsOfEpochDate,country,website,maxAge,address1,fax,industry,address2
t0,EVGN,50724000.0,40414200,4986000,,-6895000,10242000,-6210000,2467000,7000,-7446000,-7446000,,-14000,,,,3000,135000,7581000,128000,551000,,-6898000,-6210000,15677000.0,258258000.0,10894000.0,66401000.0,170000.0,87537000.0,231000.0,-192088000.0,3966000.0,12000.0,42755000.0,5326000.0,3981000.0,67867000.0,22609000.0,2503000.0,1203000.0,,8996000,232000,8772000,-149000,937000,86000,829000,4113000,539000,-6135000,574000,11000,257000,-828000,-224000,62541000.0,en-US,US,EQUITY,True,Nasdaq Real Time Price,USD,4.949999,3.02 - 3.21,3.0,3.13,3.17,13,9,finmb_3274115,NasdaqGM,USD,343051,256216,1.0685,0.513702,2.08 - 10.24,-7.0915,-0.6925293,2.08,10.24,-0.755,-0.74,-0.67,-4.6992536,-14400000,1.77,2.8519444,0.29655552,0.103983626,4.0910144,-0.9425144,4,Evogene Ltd.,Evogene Ltd.,3.1485,1630510711,0.14849997,3.14,3.21,3.02,358800,REGULAR,NGM,us_market,-0.23038648,127244104,-4.2547297,1.7788136,15,America/New_York,EDT,False,False,0,0.77,,,10.24,2.08,2.8519,4.091,343.05k,256.22k,40.41M,,39.11M,10.59%,18.41%,647.87k,2.02,1.88%,1.59%,786.22k,,,,,,0.00%,,,1:2,"Nov 18, 2013","Dec 30, 2020","Jun 29, 2021",0.00%,"-2,329.07%",-22.23%,-44.18%,1.14M,0.03,-54.70%,466k,-24.71M,-25.72M,-0.7550,,65.36M,1.61,2.39M,3.11,12.74,1.77,-22.09M,-12.44M,Value,7414002,Healthcare,131,"Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through big data and artificial intelligence, designed to computationally discover and uniquely guide the development of life-science products based on microbes, small molecules, and genetic elements. The company operates through three segments: Agriculture, Human Health, and Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. Its products focus on various crops, such as corn, soybean, wheat, rice, and cotton. The Industrial Applications segment develops enhanced castor bean seeds to serve as a feedstock source for other industrial uses. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, GI related disorders, and antimicrobial resistance organisms. The company also provides medical cannabis products. It operates in the United States, Israel, Brazil, and internationally. The company has strategic collaborations and licensing agreements with agricultural companies, such as BASF SE, Corteva, and Bayer; and through its subsidiary, Canonic Ltd., has a collaboration agreement with Cannbit Ltd., a subsidiary of Tikun Olam-Cannbit Ltd. for the development of novel medical cannabis products. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel.",Rehovot,972 8 931 1900,1609372800,Israel,http://www.evogene.com,86400,13 Gad Feinstein Street,972 8 946 6724,Biotechnology,Park Rehovot PO Box 4173
t-1,EVGN,55627000.0,40414200,4297000,,-7112000,10568000,-6602000,2024000,62000,-6259000,-6259000,,-905000,,,,8000,333000,6592000,271000,-853000,,-7120000,-6602000,15909000.0,257184000.0,10674000.0,71536000.0,170000.0,92778000.0,230000.0,-185878000.0,3740000.0,10000.0,38642000.0,5342000.0,3966000.0,72893000.0,31448000.0,2803000.0,993000.0,,-29580000,102000,-29763000,-167000,27489000,325000,27553000,-7587000,-624000,-4689000,560000,3000,103000,923000,-183000,67551000.0,en-US,US,EQUITY,True,Nasdaq Real Time Price,USD,4.949999,3.02 - 3.21,3.0,3.13,3.17,13,9,finmb_3274115,NasdaqGM,USD,343051,256216,1.0685,0.513702,2.08 - 10.24,-7.0915,-0.6925293,2.08,10.24,-0.755,-0.74,-0.67,-4.6992536,-14400000,1.77,2.8519444,0.29655552,0.103983626,4.0910144,-0.9425144,4,Evogene Ltd.,Evogene Ltd.,3.1485,1630510711,0.14849997,3.14,3.21,3.02,358800,REGULAR,NGM,us_market,-0.23038648,127244104,-4.2547297,1.7788136,15,America/New_York,EDT,False,False,0,0.77,,,10.24,2.08,2.8519,4.091,343.05k,256.22k,40.41M,,39.11M,10.59%,18.41%,647.87k,2.02,1.88%,1.59%,786.22k,,,,,,0.00%,,,1:2,"Nov 18, 2013","Dec 30, 2020","Jun 29, 2021",0.00%,"-2,329.07%",-22.23%,-44.18%,1.14M,0.03,-54.70%,466k,-24.71M,-25.72M,-0.7550,,65.36M,1.61,2.39M,3.11,12.74,1.77,-22.09M,-12.44M,Value,7414002,Healthcare,131,"Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through big data and artificial intelligence, designed to computationally discover and uniquely guide the development of life-science products based on microbes, small molecules, and genetic elements. The company operates through three segments: Agriculture, Human Health, and Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. Its products focus on various crops, such as corn, soybean, wheat, rice, and cotton. The Industrial Applications segment develops enhanced castor bean seeds to serve as a feedstock source for other industrial uses. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, GI related disorders, and antimicrobial resistance organisms. The company also provides medical cannabis products. It operates in the United States, Israel, Brazil, and internationally. The company has strategic collaborations and licensing agreements with agricultural companies, such as BASF SE, Corteva, and Bayer; and through its subsidiary, Canonic Ltd., has a collaboration agreement with Cannbit Ltd., a subsidiary of Tikun Olam-Cannbit Ltd. for the development of novel medical cannabis products. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel.",Rehovot,972 8 931 1900,1609372800,Israel,http://www.evogene.com,86400,13 Gad Feinstein Street,972 8 946 6724,Biotechnology,Park Rehovot PO Box 4173
t-2,EVGN,29906000.0,40414200,4811000,,-8738000,10837000,-8122000,2371000,5000,-7177000,-7177000,,-628000,,,,25000,351000,7528000,346000,-1561000,,-8763000,-8122000,16139000.0,225121000.0,15033000.0,46045000.0,4263000.0,71915000.0,200000.0,-179276000.0,3694000.0,9000.0,46229000.0,9676000.0,3944000.0,51823000.0,2000000.0,2168000.0,863000.0,47000.0,-29580000,37000,-103000,-155000,10746000,-630000,8903000,4735000,963000,-6871000,627000,-188000,1998000,1194000,-103000,42147000.0,en-US,US,EQUITY,True,Nasdaq Real Time Price,USD,4.949999,3.02 - 3.21,3.0,3.13,3.17,13,9,finmb_3274115,NasdaqGM,USD,343051,256216,1.0685,0.513702,2.08 - 10.24,-7.0915,-0.6925293,2.08,10.24,-0.755,-0.74,-0.67,-4.6992536,-14400000,1.77,2.8519444,0.29655552,0.103983626,4.0910144,-0.9425144,4,Evogene Ltd.,Evogene Ltd.,3.1485,1630510711,0.14849997,3.14,3.21,3.02,358800,REGULAR,NGM,us_market,-0.23038648,127244104,-4.2547297,1.7788136,15,America/New_York,EDT,False,False,0,0.77,,,10.24,2.08,2.8519,4.091,343.05k,256.22k,40.41M,,39.11M,10.59%,18.41%,647.87k,2.02,1.88%,1.59%,786.22k,,,,,,0.00%,,,1:2,"Nov 18, 2013","Dec 30, 2020","Jun 29, 2021",0.00%,"-2,329.07%",-22.23%,-44.18%,1.14M,0.03,-54.70%,466k,-24.71M,-25.72M,-0.7550,,65.36M,1.61,2.39M,3.11,12.74,1.77,-22.09M,-12.44M,Value,7414002,Healthcare,131,"Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through big data and artificial intelligence, designed to computationally discover and uniquely guide the development of life-science products based on microbes, small molecules, and genetic elements. The company operates through three segments: Agriculture, Human Health, and Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. Its products focus on various crops, such as corn, soybean, wheat, rice, and cotton. The Industrial Applications segment develops enhanced castor bean seeds to serve as a feedstock source for other industrial uses. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, GI related disorders, and antimicrobial resistance organisms. The company also provides medical cannabis products. It operates in the United States, Israel, Brazil, and internationally. The company has strategic collaborations and licensing agreements with agricultural companies, such as BASF SE, Corteva, and Bayer; and through its subsidiary, Canonic Ltd., has a collaboration agreement with Cannbit Ltd., a subsidiary of Tikun Olam-Cannbit Ltd. for the development of novel medical cannabis products. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel.",Rehovot,972 8 931 1900,1609372800,Israel,http://www.evogene.com,86400,13 Gad Feinstein Street,972 8 946 6724,Biotechnology,Park Rehovot PO Box 4173
t-3,EVGN,28556000.0,40414200,3998000,,-5411000,11140000,-4786000,1796000,241000,-5553000,-5553000,,-73000,,,,0,316000,5869000,75000,142000,,-5411000,-4786000,16374000.0,215907000.0,9915000.0,44930000.0,215000.0,65985000.0,177000.0,-171154000.0,3604000.0,9000.0,41494000.0,4639000.0,4210000.0,45392000.0,2000000.0,1898000.0,701000.0,,5000000,-343000,4836000,-155000,9793000,21000,9814000,10420000,183000,-4392000,718000,25000,134000,-27000,-164000,40753000.0,en-US,US,EQUITY,True,Nasdaq Real Time Price,USD,4.949999,3.02 - 3.21,3.0,3.13,3.17,13,9,finmb_3274115,NasdaqGM,USD,343051,256216,1.0685,0.513702,2.08 - 10.24,-7.0915,-0.6925293,2.08,10.24,-0.755,-0.74,-0.67,-4.6992536,-14400000,1.77,2.8519444,0.29655552,0.103983626,4.0910144,-0.9425144,4,Evogene Ltd.,Evogene Ltd.,3.1485,1630510711,0.14849997,3.14,3.21,3.02,358800,REGULAR,NGM,us_market,-0.23038648,127244104,-4.2547297,1.7788136,15,America/New_York,EDT,False,False,0,0.77,,,10.24,2.08,2.8519,4.091,343.05k,256.22k,40.41M,,39.11M,10.59%,18.41%,647.87k,2.02,1.88%,1.59%,786.22k,,,,,,0.00%,,,1:2,"Nov 18, 2013","Dec 30, 2020","Jun 29, 2021",0.00%,"-2,329.07%",-22.23%,-44.18%,1.14M,0.03,-54.70%,466k,-24.71M,-25.72M,-0.7550,,65.36M,1.61,2.39M,3.11,12.74,1.77,-22.09M,-12.44M,Value,7414002,Healthcare,131,"Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through big data and artificial intelligence, designed to computationally discover and uniquely guide the development of life-science products based on microbes, small molecules, and genetic elements. The company operates through three segments: Agriculture, Human Health, and Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. Its products focus on various crops, such as corn, soybean, wheat, rice, and cotton. The Industrial Applications segment develops enhanced castor bean seeds to serve as a feedstock source for other industrial uses. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, GI related disorders, and antimicrobial resistance organisms. The company also provides medical cannabis products. It operates in the United States, Israel, Brazil, and internationally. The company has strategic collaborations and licensing agreements with agricultural companies, such as BASF SE, Corteva, and Bayer; and through its subsidiary, Canonic Ltd., has a collaboration agreement with Cannbit Ltd., a subsidiary of Tikun Olam-Cannbit Ltd. for the development of novel medical cannabis products. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel.",Rehovot,972 8 931 1900,1609372800,Israel,http://www.evogene.com,86400,13 Gad Feinstein Street,972 8 946 6724,Biotechnology,Park Rehovot PO Box 4173
